- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 311/60 - Benzo [b] pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulfur atoms in position 2 or 4 with aryl radicals attached in position 2
Patent holdings for IPC class C07D 311/60
Total number of patents in this class: 101
10-year publication summary
9
|
8
|
9
|
3
|
15
|
5
|
3
|
3
|
1
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Emerald Health Therapeutics Canada Inc. | 19 |
10 |
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 165 |
6 |
The University of Queensland | 661 |
6 |
Northwestern University | 3398 |
4 |
Artax Biopharma Inc. | 18 |
3 |
Botaneco Inc. | 32 |
3 |
Sun Pharma Advanced Research Company Ltd. | 197 |
3 |
Université du Québec à Chicoutimi | 51 |
3 |
Bristol-myers Squibb Company | 4880 |
2 |
Sumitomo Chemical Company, Limited | 9043 |
2 |
AbbVie S.á.r.l. | 27 |
2 |
Beijing Shenogen Pharma Group Ltd. | 21 |
2 |
Endorecherche, Inc. | 24 |
2 |
Galapagos NV | 273 |
2 |
Inmed Pharmaceuticals Inc. | 22 |
2 |
Sanofi | 4072 |
2 |
Flavocure Biotech, Inc. | 8 |
2 |
Sandoz AG | 1417 |
1 |
The Regents of the University of California | 19961 |
1 |
Merck Patent GmbH | 5815 |
1 |
Other owners | 42 |